Institutional Biosafety Committee (IBC)

In accordance with the National Institutes of Health (NIH) Guidelines, the National Cancer Institute-Frederick (NCI-F) has established an Institutional Biosafety Committee (IBC) . The committee represents the interests of the surrounding community with respect to public health and protection of the environment, animal containment principles and biological safety.

The IBC is responsible for reviewing projects that involve, but are not limited to: rDNA/RNA; RNAi (shRNA/siRNA); Pathogens; Oncogenes; Biological Toxins; Human Materials; Other potentially infectious material (OPIM); Transgenic or Knock-Out/In Animals; Synthetic Biology; Nanotechnology; and Dual Use Materials.

Important Note:

To ensure adequate and timely review, the IBC has implemented registration submission deadlines (see right).

There will be no exceptions to this requirement.

2016 Meeting Dates

  • January 19
  • February 16
  • March 15
  • April 19
  • May 17
  • June 21
  • July 19
  • August 16
  • September 20
  • October 18
  • November 15
  • December 20

2016 Submission Deadlines

  • December 20, 2015
  • January 19
  • February 16
  • March 15
  • April 19
  • May 17
  • June 21 *
  • July 19
  • August 16
  • September 20
  • October 18
  • November 15

*Building 426 Conference Room 103, ATRF still 1201 room

All other meetings will be held in Building 549 Executive Board Room from 12:00 to 3:00.

Current Topics in Biosafety

New! Synthetic Nucleic Acid Molecules – changes to NIH Guidelines

Investigator Responsibilities under NIH Guidelines

NIH Dual Use Research

Biosecurity News in Brief

Strain database: To determine if a particular mouse strain is registered with the NCI-Frederick IBC, please contact NCI-Frederick IBC, 301-846-1451.